Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
J Cell Sci. 2011 Oct 15;124(Pt 20):3381-92. doi: 10.1242/jcs.089110.
The eukaryotic cell is organized into membrane-covered compartments that are characterized by specific sets of proteins and biochemically distinct cellular processes. The appropriate subcellular localization of proteins is crucial because it provides the physiological context for their function. In this Commentary, we give a brief overview of the different mechanisms that are involved in protein trafficking and describe how aberrant localization of proteins contributes to the pathogenesis of many human diseases, such as metabolic, cardiovascular and neurodegenerative diseases, as well as cancer. Accordingly, modifying the disease-related subcellular mislocalization of proteins might be an attractive means of therapeutic intervention. In particular, cellular processes that link protein folding and cell signaling, as well as nuclear import and export, to the subcellular localization of proteins have been proposed as targets for therapeutic intervention. We discuss the concepts involved in the therapeutic restoration of disrupted physiological protein localization and therapeutic mislocalization as a strategy to inactivate disease-causing proteins.
真核细胞组织成由膜覆盖的隔室,这些隔室的特点是具有特定的蛋白质组和生化上不同的细胞过程。蛋白质的适当亚细胞定位是至关重要的,因为它为其功能提供了生理背景。在本评论中,我们简要概述了参与蛋白质运输的不同机制,并描述了蛋白质的异常定位如何导致许多人类疾病的发病机制,如代谢、心血管和神经退行性疾病以及癌症。因此,修饰与疾病相关的蛋白质亚细胞定位错误可能是一种有吸引力的治疗干预手段。特别是,将蛋白质折叠和细胞信号转导以及核输入和输出与蛋白质的亚细胞定位联系起来的细胞过程已被提议作为治疗干预的靶点。我们讨论了恢复中断的生理蛋白质定位和治疗性错误定位作为使致病蛋白失活的策略的相关概念。